The government is now operating in accordance with the Guidance on Caretaker Conventions, pending the outcome of the 2025 federal election.
Use the filters below to narrow your search.
Filter results
You can narrow down the results using the filters.
- (-) Scheduling (national classification system) (15)
- (-) Weight loss products (7)
- Advertising (117)
- COVID-19 (91)
- Prescription medicines (76)
- Regulatory compliance (76)
- Medicine safety (66)
- COVID-19 vaccines (53)
- Therapeutic goods regulation (46)
- Safety (32)
- Vaping hub (27)
- Australian Register of Therapeutic Goods (ARTG) (16)
- Compliance and enforcement hub (16)
- Import and export (16)
- Over the counter (OTC) medicines (14)
- Complementary medicines (13)
- Medical devices safety (13)
- Medicinal cannabis hub (13)
- Alert/Advisory (12)
- Listed medicines (12)
- Non-prescription medicines (12)
- Labelling and packaging (11)
- Shortages (10)
- Manufacturing (7)
- Legislation (6)
- In Vitro Diagnostic medical devices (IVDs) (5)
- Assessed listed medicines (3)
- Cosmetics (3)
- Sunscreens (3)
- Registered complementary medicines (2)
- Advisory bodies and committees (1)
- Blood safety (1)
- Breast implant hub (1)
- Prescription opioids hub (1)
- Travelling with health products (1)
Search
22 result(s) found, displaying 1 to 22
-
Compliance undertakingsWe have accepted a court-enforceable undertaking from Your Solution Compounding Pharmacy Pty Ltd, regarding advertising of prescription-only compounded medicines for weight-loss.
-
Media releasesWe have accepted a court-enforceable undertaking from Your Solution Compounding Pharmacy Pty Ltd, regarding advertising of prescription-only compounded medicines for weight-loss.
-
BlogIf your business sells or advertises paracetamol, then you need to be aware of the new rules around pack sizes that commence on 1 February 2025.
-
NoticesThis instrument is made under section 39 of the current Poisons Standard.
-
NoticesThis instrument is made under section 39 of the current Poisons Standard.
-
NoticesWe are providing a 12-month period of labelling exemptions for signal words for certain Pharmacy medicine and Pharmacist Only medicine products.
-
Media releasesAmendments to the Therapeutic Goods Regulations 1990 (Schedule 5, item 6) have been made resulting in compounded GLP-1 RA products no longer being able to be compounded by pharmacists and supplied to patients.
-
NoticesThis instrument is the Therapeutic Goods (Poisons Standard) (Benzylpenicillin—Seqirus) Approval 2024.
-
BlogSome online health clinics are advertising and selling compounded medicines. However, it is important to know that compounded products are not identical to TGA approved products.
-
NewsFind out about changes to choline salicylate access, starting from October 2023.
-
NewsStay updated about the commencement of MDMA and psilocybin for the treatment of certain mental illnesses.
-
Media releasesThe TGA has published a final decision to reduce the maximum size of packs for various paracetamol products.
-
Media releasesFrom 1 June 2023, prescribing of oral ivermectin for ‘off-label’ uses will no longer be limited to specialists such as dermatologists, gastroenterologists and infectious diseases specialists.
-
BlogFrom 1 July 2023, authorised psychiatrists can prescribe psychedelic medicines to people with specific mental health conditions under strict controls.
-
Media releasesThe TGA is aware of several scams targeting consumers seeking semaglutide (Ozempic). Consumers are strongly advised not to use products unless they have come from a trusted source.
-
NewsSupplies of Ozempic (semaglutide) have begun distribution in Australia but will remain quite limited for some time.
-
Media releasesThe TGA has today published an interim decision to reduce the maximum pack sizes for various paracetamol products.
-
Media releasesFrom 1 July this year, medicines containing the psychedelic substances psilocybin and MDMA can be prescribed by specifically authorised psychiatrists for the treatment of certain mental health conditions.
-
NewsBefore you take a weight loss supplement or medicine, there are things to consider.
-
Media releasesThe TGA has published an independent expert report examining the incidence of serious injury and death from intentional paracetamol overdose.
-
NoticesThis labelling exemption is granted under section 1.1(3) of Part 2 of the current Poisons Standard.
-
Media releasesToday the TGA announced a final decision to down-schedule certain low dose cannabidiol (CBD) preparations